SYSTEMATIC REVIEW OF THE EFFECTIVENESS AND SAFETY OF SUBCUTANEOUS SEMAGLUTIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND OBESITY. YHCĐ. 2026;67(CĐ8-NCKH). doi:10.52163/yhc.v67iCD8.5720